Publication
Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22
| dc.contributor.author | Guerra Leal, Bárbara | |
| dc.contributor.author | Barros-Barbosa, Aurora | |
| dc.contributor.author | Ferreirinha, Fátima | |
| dc.contributor.author | Chaves, João | |
| dc.contributor.author | Rangel, Rui | |
| dc.contributor.author | Santos, Agostinho | |
| dc.contributor.author | Carvalho, Cláudia | |
| dc.contributor.author | Martins-Ferreira, Ricardo | |
| dc.contributor.author | Samões, Raquel | |
| dc.contributor.author | Freitas, Joel | |
| dc.contributor.author | Lopes, João | |
| dc.contributor.author | Ramalheira, João | |
| dc.contributor.author | Lobo, Maria Graça | |
| dc.contributor.author | Martins da Silva, António | |
| dc.contributor.author | Costa, Paulo P. | |
| dc.contributor.author | Correia-de-Sá, Paulo | |
| dc.date.accessioned | 2023-03-21T11:38:05Z | |
| dc.date.available | 2023-03-21T11:38:05Z | |
| dc.date.issued | 2022-07-07 | |
| dc.description.abstract | Objective: ATP-gated ionotropic P2X7 receptors (P2X7R) actively participate in epilepsy and other neurological disorders. Neocortical nerve terminals of patients with Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis (MTLE-HS) express higher P2X7R amounts. Overexpression of P2X7R bolsters ATP signals during seizures resulting in glial cell activation, cytokines production, and GABAergic rundown with unrestrained glutamatergic excitation. In a mouse model of status epilepticus, increased expression of P2X7R has been associated with the down-modulation of the non-coding micro RNA, miR-22. MiR levels are stable in biological fluids and normally reflect remote tissue production making them ideal disease biomarkers. Here, we compared P2X7R and miR-22 expression in epileptic brains and in the serum of patients with MTLE-HS, respectively. Methods: Quantitative RT-PCR was used to evaluate the expression of P2X7R in the hippocampus and anterior temporal lobe of 23 patients with MTLE-HS and 10 cadaveric controls. Confocal microscopy and Western blot analysis were performed to assess P2X7R protein amounts. MiR-22 expression was evaluated in cell-free sera of 40 MTLE-HS patients and 48 healthy controls. Results: Nerve terminals of the hippocampus and neocortical temporal lobe of MTLE-HS patients overexpress (p < 0.05) an 85 kDa P2X7R protein whereas the normally occurring 67 kDa receptor protein dominates in the brain of the cadaveric controls. Contrariwise, miR-22 serum levels are diminished (p < 0.001) in MTLE-HS patients compared to age-matched control blood donors, a situation that is more evident in patients requiring multiple (>3) anti-epileptic drug (AED) regimens. Conclusion: Data show that there is an inverse relationship between miR-22 serum levels and P2X7R expression in the hippocampus and neocortex of MTLE-HS patients, which implies that measuring serum miR-22 may be a clinical surrogate of P2X7R brain expression in the MTLE-HS. Moreover, the high area under the ROC curve (0.777; 95% CI 0.629-0.925; p = 0.001) suggests that low miR-22 serum levels may be a sensitive predictor of poor response to AEDs among MTLE-HS patients. Results also anticipate that targeting the miR-22/P2X7R axis may be a good strategy to develop newer AEDs. | pt_PT |
| dc.description.sponsorship | This research was partial funded by a BICE Tecnifar Grant. The work performed in PC-S’s Lab was partially supported by UP/Santander Totta and Fundação para a Ciência e Tecnologia (FCT, POCTI PTDC/SAU-PUB/28311/2017—EPIRaft grant and Fundo Europeu de Desenvolvimento Regional—FEDER funding and COMPETE—MedInUP projects Pest-OE/SAU/UI215/2014, UID/BIM/4308/2016, UIDB/04308/2020 and UIDP/04308/2020). Unit for Multidisciplinary Research in Biomedicine (UMIB) is funded by the Foundation for Science and Technology (FCT) Portugal (grant numbers UIDB/00215/2020 and UIDP/00215/2020) and ITR—Laboratory for Integrative and Translational Research in Population Health (LA/P/0064/2020). RM-F was in receipt of an FCT PhD studentship (SFRH/BD/137900/2018). | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Front Cell Neurosci. 2022 Jul 7;16:910662. doi: 10.3389/fncel.2022.910662. eCollection 2022. | pt_PT |
| dc.identifier.doi | 10.3389/fncel.2022.910662 | pt_PT |
| dc.identifier.issn | 1662-5102 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/8584 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Frontiers Media | pt_PT |
| dc.relation | Pest-OE/SAU/UI215/2014 | pt_PT |
| dc.relation | Contribution of neuronal membrane and lipid raft remodelling to the pathophysiology of mesial temporal lobe epilepsy (MTLE): insight into the beneficial effects of the ketogenic diet therapy. | |
| dc.relation | Centro de Investigação Farmacológica e Inovação Medicamentosa | |
| dc.relation | Center for Drug Discovery and Innovative Medicines | |
| dc.relation | Center for Drug Discovery and Innovative Medicines | |
| dc.relation.publisherversion | https://www.frontiersin.org/articles/10.3389/fncel.2022.910662/full | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | P2X7 Purinoceptor | pt_PT |
| dc.subject | Hippocampus | pt_PT |
| dc.subject | Mesotemporal Lobe Epilepsy | pt_PT |
| dc.subject | miR-22 | pt_PT |
| dc.subject | microRNAs | pt_PT |
| dc.subject | Refractory Epilepsy | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.title | Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22 | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Contribution of neuronal membrane and lipid raft remodelling to the pathophysiology of mesial temporal lobe epilepsy (MTLE): insight into the beneficial effects of the ketogenic diet therapy. | |
| oaire.awardTitle | Centro de Investigação Farmacológica e Inovação Medicamentosa | |
| oaire.awardTitle | Center for Drug Discovery and Innovative Medicines | |
| oaire.awardTitle | Center for Drug Discovery and Innovative Medicines | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FSAU-PUB%2F28311%2F2017/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FBIM%2F4308%2F2016/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04308%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04308%2F2020/PT | |
| oaire.citation.startPage | 910662 | pt_PT |
| oaire.citation.title | Frontiers in Cellular Neuroscience | pt_PT |
| oaire.citation.volume | 16 | pt_PT |
| oaire.fundingStream | 9471 - RIDTI | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| rcaap.embargofct | Acesso de acordo com política editorial da revista. | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isProjectOfPublication | 77eb58c9-6c2b-473c-ae3d-1ffd36275829 | |
| relation.isProjectOfPublication | 6aa4310c-4668-43fb-84c9-8404b007839e | |
| relation.isProjectOfPublication | 631215b6-7334-4aae-90c4-35073eb25b70 | |
| relation.isProjectOfPublication | 5dd0abb5-337a-46a3-815f-2894311ae467 | |
| relation.isProjectOfPublication.latestForDiscovery | 631215b6-7334-4aae-90c4-35073eb25b70 |
